|
AM1009a-ev
|
Abcepta, Inc.
|
GFP Tag [168AT1211], Mouse Monoclonal Antibody
|
Human
|
WB, IF
|
|
|
AM1009a
|
Abcepta, Inc.
|
GFP Tag [168AT1211], Mouse Monoclonal Antibody
|
Human
|
WB, IF
|
|
|
AM1009b
|
Abcepta, Inc.
|
GFP Tag [Ascites] [168AT1211.269.64], Mouse Monoclonal Antibody
|
|
WB
|
|
|
PDC02-0100
|
Bio-Helix Co., Ltd
|
PureDireX Genomic DNA Isolation Dual kit
|
|
|
|
|
PDR05-0100
|
Bio-Helix Co., Ltd
|
PureDireX Genomic DNA Isolation Reagent Kit (Blood/Cultured Cell/Tissue)
|
|
|
|
|
HY-135932-50mg
|
MedChemexpress LLC
|
m-PEG8-O-alkyne [CAS 880081-81-2]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-10mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-100mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-25mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-5mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-50mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-1mL
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-140521-100mg
|
MedChemexpress LLC
|
N-(Acid-PEG2)-N-bis(PEG3-azide) [CAS 2320560-35-6]
|
|
Cancer-programmed cell death
|
|
|
HY-140521-50mg
|
MedChemexpress LLC
|
N-(Acid-PEG2)-N-bis(PEG3-azide) [CAS 2320560-35-6]
|
|
Cancer-programmed cell death
|
|
|
HY-140091-100mg
|
MedChemexpress LLC
|
N-(Aminooxy-PEG2)-N-bis(PEG3-propargyl) [CAS 2112737-71-8]
|
|
Cancer-programmed cell death
|
|
|
HY-140091-25mg
|
MedChemexpress LLC
|
N-(Aminooxy-PEG2)-N-bis(PEG3-propargyl) [CAS 2112737-71-8]
|
|
Cancer-programmed cell death
|
|
|
HY-140091-250mg
|
MedChemexpress LLC
|
N-(Aminooxy-PEG2)-N-bis(PEG3-propargyl) [CAS 2112737-71-8]
|
|
Cancer-programmed cell death
|
|
|
HY-140091-50mg
|
MedChemexpress LLC
|
N-(Aminooxy-PEG2)-N-bis(PEG3-propargyl) [CAS 2112737-71-8]
|
|
Cancer-programmed cell death
|
|
|
HY-140087-100mg
|
MedChemexpress LLC
|
N-(Amino-PEG2)-N-bis(PEG3-azide)
|
|
Cancer-programmed cell death
|
|
|
HY-140087-25mg
|
MedChemexpress LLC
|
N-(Amino-PEG2)-N-bis(PEG3-azide)
|
|
Cancer-programmed cell death
|
|
|
HY-140087-50mg
|
MedChemexpress LLC
|
N-(Amino-PEG2)-N-bis(PEG3-azide)
|
|
Cancer-programmed cell death
|
|
|
HY-140867-100mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-bis(PEG4-Boc) [CAS 2112731-81-2]
|
|
Cancer-programmed cell death
|
|
|
HY-140867-250mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-bis(PEG4-Boc) [CAS 2112731-81-2]
|
|
Cancer-programmed cell death
|
|
|
HY-140867-50mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-bis(PEG4-Boc) [CAS 2112731-81-2]
|
|
Cancer-programmed cell death
|
|
|
HY-140562-100mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-Boc-PEG3-Boc [CAS 2093153-07-0]
|
|
Cancer-programmed cell death
|
|
